{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:29Z","timestamp":1791839969831,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd008564.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000}}],"reference-count":104,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008564.pub3","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:55:20Z","timestamp":1728989720000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Blood pressure targets for hypertension in people with chronic renal disease"],"prefix":"10.1002","volume":"2024","author":[{"given":"Juan","family":"Erviti","sequence":"additional","affiliation":[{"name":"Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain"},{"name":"IdiSNA, Navarra Institute for Health Research; Pamplona Spain"},{"name":"Public University of Navarre; Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"Saiz","sequence":"additional","affiliation":[{"name":"Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain"},{"name":"IdiSNA, Navarra Institute for Health Research; Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Leache","sequence":"additional","affiliation":[{"name":"Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain"},{"name":"IdiSNA, Navarra Institute for Health Research; Pamplona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 I","family":"Pijoan","sequence":"additional","affiliation":[{"name":"Hospital Universitario Cruces; Barakaldo Spain"},{"name":"CIBERESP, Center Network for Epidemiology and Public Health, Instituto Carlos III, Spain; Madrid Spain"},{"name":"Biobizkaia Health Research Institute; Barakaldo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Men\u00e9ndez Orenga","sequence":"additional","affiliation":[{"name":"CIBERESP, Center Network for Epidemiology and Public Health, Instituto Carlos III, Spain; Madrid Spain"},{"name":"Primary Care; Servicio Madrile\u00f1o de Salud; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M","family":"Salzwedel","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"M\u00e9ndez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"IdiSNA, Navarra Institute for Health Research; Pamplona Spain"},{"name":"Department of Internal Medicine; University Hospital of Navarre, Navarre Health Service; Pamplona\/Iru\u00f1a Spain"},{"name":"Navarrabiomed-Public University of Navarre, Pamplona (UPNA); Pamplona\/Iru\u00f1a Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"issue":"19","key":"10.1002\/14651858.CD008564.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2421\u201331","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Bakris","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"The ACCORD Study Group","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"9118","key":"10.1002\/14651858.CD008564.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/s0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD008564.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"10.1002\/14651858.CD008564.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood pressure control","volume":"373","author":"The SPRINT Research Group","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"9891","key":"10.1002\/14651858.CD008564.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"The SPS3 Study Group","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3109\/08037059409102265","article-title":"The BBB Study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in \u201cwell-treated\u201d hypertensive patients","volume":"3","author":"Hansson","year":"1994","journal-title":"Blood Pressure"},{"issue":"9689","key":"10.1002\/14651858.CD008564.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD008564.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ahj.2012.11.008","article-title":"INtensive versus standard ambulatory blood pressure lowering to prevent Functional DeclINe In The elderlY (INFINITY)","volume":"165","author":"White","year":"2013","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0010|cit10","unstructured":"Effect of intensive blood pressure control on progression of coronary atherosclerosis: randomized evaluation by intravascular ultrasound (PREVUS) clinicaltrials.gov\/ct2\/show\/NCT01230216"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/1745-6215-14-401","article-title":"Prevention of decline in cognition after stroke trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids","volume":"14","author":"Blackburn","year":"2022","journal-title":"Trials"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000353795","article-title":"Rationale of the REstart or Stop Antithrombotics Randomised Trial in Asia Pacific (RESTART-AP)","volume":"36 (Suppl 1)","author":"Arima","year":"2013","journal-title":"Cerebrovascular Diseases (Basel, Switzerland)"},{"issue":"10","key":"10.1002\/14651858.CD008564.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008564.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0272-6386(99)70036-3","article-title":"Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy","volume":"34","author":"Lewis","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0015|cit15","unstructured":"Hypertension control based on home blood pressure clinicaltrials.gov\/ct2\/show\/NCT00198562"},{"issue":"6","key":"10.1002\/14651858.CD008564.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/jamaneurol.2017.5153","article-title":"Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease: the PRESERVE randomized clinical trial","volume":"75","author":"Croall","year":"2018","journal-title":"JAMA Neurology"},{"issue":"9463","key":"10.1002\/14651858.CD008564.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD008564.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurology"},{"issue":"14","key":"10.1002\/14651858.CD008564.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ahj.2022.12.003","article-title":"Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial","volume":"257","author":"Liu","year":"2023","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0022|cit22","unstructured":"Effects of intensive systolic blood pressure lowering treatment in reducing risk of vascular events (ESPRIT) study clinicaltrials.gov\/ct2\/show\/NCT04030234"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0023|cit23","unstructured":"Pilot to examine risk and feasibility of remote management of BP From CKD through ESRD (PERFORMANCE) clinicaltrials.gov\/ct2\/show\/NCT02975505"},{"issue":"6","key":"10.1002\/14651858.CD008564.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology (ACC)\/American Heart Association (AHA) Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fphar.2020.00729","article-title":"Taking a step further in identifying ideal blood pressure range among hemodialysis patients: a systematic review and a meta-analysis","volume":"11","author":"Aftab","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008564.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/jcp.2005.035592","article-title":"Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update","volume":"60","author":"Alsaad","year":"2007","journal-title":"Journal of Clinical Pathology"},{"issue":"3","key":"10.1002\/14651858.CD008564.pub3-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004349.pub2","article-title":"Treatment blood pressure targets for hypertension","author":"Arguedas","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD008564.pub3-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008277.pub2","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","author":"Arguedas","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"33","key":"10.1002\/14651858.CD008564.pub3-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1093\/eurheartj\/ehy337","article-title":"J-curves in hypertension: what do they tell us about treatment of high blood pressure?","volume":"39","author":"Auer","year":"2018","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD008564.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"18","key":"10.1002\/14651858.CD008564.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008564.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD008564.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MNH.0000000000000124","article-title":"Podocyte injury and repair mechanisms","volume":"24","author":"Cellesi","year":"2015","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0034|cit34","unstructured":"Covidence Veritas Health Innovation 2019"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0035|cit35","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"33","key":"10.1002\/14651858.CD008564.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"10022","key":"10.1002\/14651858.CD008564.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/s0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD008564.pub3-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/hypertensionaha.116.08499","article-title":"Optimal systolic blood pressure levels for primary prevention of stroke in general hypertensive adults: findings from the CSPPT (China Stroke Primary Prevention Trial)","volume":"69","author":"Fan","year":"2017","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.265.4.489","article-title":"The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?","volume":"265","author":"Farnett","year":"1991","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD008564.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"Art. No.: ED000","DOI":"10.1002\/14651858.ED000148","article-title":"Risk of Bias 2 in Cochrane Reviews: a phased approach for the introduction of new methodology","volume":"10","author":"Flemyng","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008564.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11906-011-0228-5","article-title":"Blood pressure targets for patients with diabetes or kidney disease","volume":"13","author":"Flynn","year":"2011","journal-title":"Current Hypertension Reports"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/ibpc.s286957","article-title":"The diastolic blood pressure J-curve in hypertension management: links and risk for cardiovascular disease","volume":"14","author":"Gaffney","year":"2021","journal-title":"Integrated Blood Pressure Control"},{"issue":"8","key":"10.1002\/14651858.CD008564.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011575.pub2","article-title":"Blood pressure targets for hypertension in older adults","author":"Kolber","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0046|cit46","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2021"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0047|cit47","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0048|cit48","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0049|cit49","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0050|cit50","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MNH.0b013e3282f88a1f","article-title":"Hypertensive nephrosclerosis","volume":"17","author":"Hill","year":"2008","journal-title":"Current Opinions in Nephrology and Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD008564.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children","volume":"36","author":"Rabi","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0053|cit53","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonized Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting E2A; October 1994 Available at www.ema.europa.eu\/en\/ich-e2a-clinical-safety-data-management-definitions-standards-expedited-reporting-scientific"},{"issue":"6","key":"10.1002\/14651858.CD008564.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"International Society of Hypertension Global Hypertension Practice Guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD008564.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008564.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.275.20.1571","article-title":"Blood pressure as a cardiovascular risk factor: prevention and treatment","volume":"275","author":"Kannel","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD008564.pub3-BIB0058|cit58","first-page":"337","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"2","author":"CKD-MBD Update Work Group","year":"2012","journal-title":"Kidney International Supplements"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0059|cit59","first-page":"19","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Chapter 1: definition and classification of CKD","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney International Supplements"},{"issue":"3s","key":"10.1002\/14651858.CD008564.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of blood pressure in Chronic Kidney Disease","volume":"99","year":"2021","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD008564.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/nejm199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008564.pub3-BIB0062|cit62","first-page":"63","article-title":"Prevention of progression of nephropathy","volume":"12","author":"Klahr","year":"1997","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney International Supplements"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.119.012749","article-title":"Effect of blood pressure control on long-term risk of end-stage renal disease and death among subgroups of patients with chronic kidney disease","volume":"8","author":"Ku","year":"2019","journal-title":"Journal of the American Heart Association"},{"issue":"9349","key":"10.1002\/14651858.CD008564.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD008564.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney International"},{"issue":"11","key":"10.1002\/14651858.CD008564.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies collected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD008564.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008564.pub3-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.hyp.0000441190.09494.e9","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the argument","volume":"63","author":"Mancia","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0072|cit72","first-page":"S74","article-title":"Effect of antihypertensive therapy on the progression of non-diabetic renal disease","volume":"38 Suppl 1","author":"Mann","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008564.pub3-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"55","author":"Muntner","year":"2010","journal-title":"American Journal of Kidney Disorders"},{"issue":"5-6","key":"10.1002\/14651858.CD008564.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/10641969909060985","article-title":"An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration","volume":"21","author":"Neal","year":"1999","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0075|cit75","volume-title":"Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34; 2011. Updated August 2019","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2019"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0076|cit76","volume-title":"Chronic Kidney Disease: Assessment and Management; 2021","author":"National Institute for Health and Care Excellence (NICE)","year":"2021"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Oparil","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008564.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Systematic Reviews"},{"issue":"9349","key":"10.1002\/14651858.CD008564.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Prospective Studies Collaboration","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.amjcard.2008.07.060","article-title":"The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years","volume":"102","author":"Rashidi","year":"2008","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0082|cit82","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"7","key":"10.1002\/14651858.CD008564.pub3-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010315.pub3","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","author":"Saiz","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0084|cit84","unstructured":"Saiz LC Leache L Erviti J Individual patient data as a key modifier of Cochrane Review results: the SPS3 trial case In: Abstracts of the 25th Cochrane Colloquium, Edinburgh, UK. Cochrane Database of Systematic Reviews 2018 9 Suppl 1 142 10.1002\/14651858.CD201801"},{"issue":"11","key":"10.1002\/14651858.CD008564.pub3-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010315.pub5","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","author":"Saiz","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008564.pub3-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/ndt\/gfm757","article-title":"Blood pressure measures and risk of chronic kidney disease in men","volume":"23","author":"Schaeffner","year":"2008","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0087|cit87","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations The GRADE Working Group"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/archinte.153.5.598","article-title":"Blood pressure, systolic and diastolic and cardiovascular risk. US population data","volume":"153","author":"Stamler","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0089|cit89","first-page":"I4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD008564.pub3-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.7326\/l15-5103-2","article-title":"Effects of blood pressure reduction in mild hypertension","volume":"163","author":"Sundstrom","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD008564.pub3-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.7326\/m21-2571","article-title":"Targeting the standardized blood pressure: new guidelines for blood pressure management in chronic kidney disease","volume":"174","author":"Thomas","year":"2021","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD008564.pub3-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/hjh.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0093|cit93","unstructured":"Tierney JF Stewart LA Clarke M Chapter 26: Individual participant data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD008564.pub3-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.7326\/m21-0834","article-title":"Management of blood pressure in patients with chronic kidney disease not receiving dialysis: synopsis of the 2021 KDIGO Clinical Practice Guideline","volume":"174","author":"Tomson","year":"2021","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/jamainternmed.2017.0197","article-title":"Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease. A systematic review and meta-analysis","volume":"177","author":"Tsai","year":"2017","journal-title":"JAMA Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD008564.pub3-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/01.hyp.0000439102.43479.43","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: con side of the argument","volume":"63","author":"Verdecchia","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/01.HYP.34.6.1181","article-title":"J-shaped relation between blood pressure and stroke in treated hypertensives","volume":"34","author":"Vok\u00f3","year":"1999","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0099|cit99","volume-title":"Guideline for the Pharmacological Treatment of Hypertension in Adults","author":"World Health Organization","year":"2021"},{"issue":"19","key":"10.1002\/14651858.CD008564.pub3-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Bakris","year":"2002","journal-title":"JAMA"},{"issue":"10017","key":"10.1002\/14651858.CD008564.pub3-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/s0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0102|cit102","first-page":"e066045","article-title":"Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis","volume":"375","author":"Yao","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008564.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/00004872-200304000-00024","article-title":"Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk-profiles: does a J-shaped curve exist in smokers?","volume":"21","author":"Zanchetti","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD008564.pub3-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008564.pub2","article-title":"Blood pressure targets for hypertension in people with chronic renal disease","author":"Erviti","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:04:42Z","timestamp":1771200282000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008564.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":104,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008564.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}